Table 2.
Clinical parameters of CA-AKI subjects at 1-and 4-month follow-ups.
| Characteristics | Total no. of patients (n = 28) | Recovered (n = 14) | Incompletely recovered (n = 14) | p-value |
|---|---|---|---|---|
| At 1 month after discharge | ||||
| SCr (mg/dl) | 2.22 ± 1.29 | 1.00 ± 0.23 | 1.56 ± 0.47 | 0.005 |
| eGFR (ml/min/1.73 m2) | 118.85 ± 65.39 | 82.28 ± 25.41 | 50.19 ± 17.95 | 0.005 |
| uPCR | 0.92 ± 0.28 | 0.18 ± 0.09 | 0.35 ± 0.27 | 0.178 |
| At 4 month after discharge | ||||
| SCr (mg/dl) | 2.20 ± 1.16 | 0.89 ± 0.19 | 1.44 ± 0.50 | 0.005 |
| eGFR (ml/min/1.73 m2) | 113.44 ± 74.62 | 94.32 ± 18.99 | 54.92 ± 22.65 | 0.001 |
| uPCR | 0.75 ± 0.34 | 0.24 ± 0.10 | 0.46 ± 0.22 | 0.023 |
Continuous variables are expressed as mean ± SD or number (percentage); SCr, serum creatinine; eGFR, estimated glomerular filtration rate; uPCR, urine protein creatinine ratio.